In Brief
How Wnt signaling coordinates vascular remodeling and barrier maturation in the retina is poorly understood. Mazzoni et al. demonstrate that mice lacking Apcdd1 exhibit decreased vessel pruning and precocious formation of the blood-retina barrier. Conversely, Apcdd1 overexpression in endothelial cells induces the opposite phenotype. Apcdd1 precisely sculpts Wnt activity to coordinate vascular pruning and barrier maturation.
INTRODUCTION
Forming a functional vertebrate vascular network requires coordination of tissue-specific angiogenesis with endothelial cell (EC) differentiation, so that vessels adopt the specialized functions appropriate to the organs they subserve (Adams and Alitalo, 2007; Potente et al., 2011) . In the murine central nervous system (CNS), angiogenesis is tightly coordinated with the acquisition of EC barrier properties, known as the blood-brain barrier (BBB) , that prevent free diffusion of molecules between the blood and the CNS (Chow and Gu, 2015; Zhao et al., 2015) . Brain angiogenesis occurs during both embryonic and postnatal development, when ECs invade the neuroepithelium from the perivascular plexus, whereas retinal angiogenesis occurs exclusively at postnatal stages, with ECs from the brain invading the optic nerve (Mancuso et al., 2008; Stahl et al., 2010) . During vessel development, CNS ECs tightly coordinate angiogenesis with both vessel pruning and formation of a functional barrier. The latter features three unique properties: (1) presence of tight junction (TJ) proteins that limit paracellular permeability between ECs, (2) a low rate of receptor-mediated endocytosis (transcellular permeability), and (3) expression of transporter proteins to facilitate bidirectional transport of molecules across the endothelium (Klaassen et al., 2013; Obermeier et al., 2013) . Although CNS angiogenesis and barrier maturation are tightly coordinated, the mechanisms through which this is achieved remain unclear.
The Wnt/b-catenin pathway controls both CNS angiogenesis and barrier development (Daneman et al., 2009; Liebner et al., 2008; Stenman et al., 2008; Zhou et al., 2014) . Canonical Wnts regulate vascular morphogenesis through stabilization and translocation of b-catenin into the nucleus to induce the transcriptional targets that control angiogenesis, proliferation, survival, and barrier formation (Dejana, 2010) . While angiogenesis and barrier formation in most brain regions are promoted by activation of b-catenin through the Wnt-7a/b/Frizzled/Lrp5/6 ligandreceptor complex, in the retina and cerebellum these functions are provided by the related Norrin/Frizzled-4/Lrp5/6 signaling module (Wang et al., 2012; Ye et al., 2009; Zhou et al., 2014) . Signal specificity is dictated by the presence of obligatory unique co-receptors such as GRP-124/Reck for Wnt-7a/b and Tspan-12 for Norrin (Cho et al., 2017; Junge et al., 2009; Lai et al., 2017) . Loss-of-function (LOF) studies for the genes Ndp (encoding Norrin), , Lrp5/6, in mouse retinae all show delayed and incomplete growth of the primary vascular plexus as well as loss of deep vascular plexi (Chen et al., 2012; Junge et al., 2009; Luhmann et al., 2005; Xia et al., 2010; Ye et al., 2009; Zuercher et al., 2012) . Inhibiting Norrin/ Fz4/Lrp5/6 signaling also results in loss of blood-retina barrier (BRB) integrity, indicating that the canonical pathway is essential for BRB formation and maintenance (Paes et al., 2011; Wang et al., 2012) . Although Wnt activity is reduced in CNS ECs as they transition from a highly angiogenic to a more quiescent, ''barrier-forming'' state (Daneman et al., 2009; Liebner et al., 2008; Wang et al., 2012) , to date it has not been demonstrated whether distinct levels of Wnt signaling regulate angiogenesis versus remodeling and barrier maturation within retinal ECs.
Adenomatous polyposis coli downregulated 1 (Apcdd1), a membrane-bound glycoprotein with a highly conserved cysteine-rich region in its extracellular domain, is both a downstream target and inhibitor of the canonical Wnt pathway (Shimomura et al., 2010; Takahashi et al., 2002) . Apcdd1 was identified as the second-most enriched gene in brain ECs compared to lung and liver endothelium and is uniquely expressed within the CNS vasculature (Daneman et al., 2010a) . Moreover, Apcdd1 mRNA levels decrease in both Norrin À/À and Lrp5 À/À retinas, indicating that it is a target for Norrin/Fz4/Lrp5/6 signaling (Chen et al., 2012) . Apcdd1 blocks the interaction between Wnt3A and Lrp5, thus inhibiting downstream stabilization of b-catenin and several Wnt-mediated developmental processes including embryonic axis specification, neural proliferation, and hair follicle formation (Shimomura et al., 2010) . These findings suggest that Apcdd1 may be a key regulator of Wnt activity that coordinates CNS angiogenesis and BRB formation.
To determine whether Apcdd1 is required for retinal angiogenesis and barrier formation in the retina, we have generated Apcdd1-deficient mice and examined retinal vascular densities during development. While the initial stages of retinal angiogenesis are normal, Apcdd1-deficient mice exhibit a transient increase in vessel density between postnatal days 10 and 12 (P10 and P12), due to decreased vessel pruning. Conversely, Apcdd1 À/À mice display accelerated BRB maturation, as evidenced by decreased paracellular permeability of retinal blood vessels to low-molecular-weight tracers. Primary brain ECs isolated from Apcdd1 À/À mice also display abnormal paracellular and transcellular barrier properties, suggesting that the gene functions cell autonomously in ECs. Conversely, mice that overexpress Apcdd1 in retinal endothelial cells have reduced vessel density but increased paracellular barrier permeability. These findings provide evidence that Apcdd1 precisely adjusts levels of canonical Wnt signaling to coordinate the timing of vascular pruning with barrier maturation in the developing retina.
RESULTS

Apcdd1 Is Expressed Postnatally in Retinal Blood Vessels
To investigate the function of Apcdd1 in retinal angiogenesis and BRB function, we first determined the expression of Apcdd1 mRNA from P6 to P17 by RNA in situ hybridization. Apcdd1 mRNA is expressed in the superficial vascular plexus present within the ganglion cell layer (GCL) of the retina at P6 ( Figure 1A , white arrow). Apcdd1 mRNA is also detected in the inner nuclear layer (INL) at P8, when the superficial plexus begins to branch into deeper layers of the retina to form the deep plexi ( Figure 1C , white arrows). Retinal vascular expression of Apcdd1 mRNA persists to P12 and P17 (Figures 1E and 1G, white arrows) and mirrors that of Claudin-5, a marker for blood vessels ( Figures   1B, 1D , 1F, and 1H). We confirmed expression of Apcdd1 mRNA in endothelial cells using RNA in situ hybridization for Apcdd1 mRNA coupled with immunohistochemistry for Caveolin-1, an EC marker, in P12 and P17 wild-type retinas ( Figures  1I-1L , white arrows). However, Apcdd1 mRNA has very little colocalization with PDGFRb mRNA, a marker for pericytes, by double fluorescent RNA in situ hybridization ( Figures 1M-1P , S1A, and S1B). Apcdd1 mRNA is also expressed in other regions of the eye, including the neuroblast layer (NBL) and INL ( Figures  1A, 1C , 1E, and 1G; yellow arrows); however, it does not colocalize with Sox9 mRNA (a M€ uller glia marker; Figures S1C-S1E) suggesting that neuroglial progenitors or neurons produce Apcdd1. These results demonstrate that Apcdd1 mRNA is present in endothelial cells, but not pericytes, during the establishment of both superficial and deep plexi, as well as in a few other cell types.
Loss of Apcdd1 Leads to a Transient Increase in Vessel Density
To examine whether Apcdd1 affects retinal angiogenesis, we used a previously described Apcdd1 mutant strain in which loxP sites had been engineered to flank exons 2 and 3 (Figure S2A ) (Turakainen et al., 2009) . Deletion of these exons introduces a premature stop codon after splicing to terminate translation, resulting in a truncated and presumably non-functional protein. We crossed Apcdd1Ex2,3 flox/flox mice to a strain bearing the Cre recombinase under a heat shock promoter (Dietrich et al., 2000) and P12 have increased vessel density within the perivenous capillary beds at the leading edge of the retinal leaflet compared to those from littermate controls ( Figures 2E-2L , white arrows). Vessel density in the retina increases from 38% to 43% at P10 and from 23% to 27% at P12 in Apcdd1 À/À compared to wildtype littermates ( Figure 2N ). However, this hypervascularized phenotype is resolved by P14, indicating a transient defect in vascular density. Moreover, Apcdd1 À/À mice have increased vein diameters at P10 ( Figures 2F, 2H , and 2P); however, there was no change in arterial diameter from P8 to P12 ( Figure 2O ). These data demonstrate that loss of Apcdd1 causes both a transient increase in vessel density and vein abnormalities within the retina. Because Apcdd1 is a target for Norrin/Fz4/Lrp5/6 signaling in retinal blood vessels (Chen et al., 2012) , we examined whether the hypervascularization phenotype is due to increased Norrin/ Fz4/Lrp5/6 signaling and b-catenin activity in ECs. We measured expression levels of Sox17, a Wnt/b-catenin target gene Lengfeld et al., 2017; Zhou et al., 2015) S3D and S3M ). An alternative explanation for increased vessel density could be delayed vessel pruning, a critical developmental stage of vascular remodeling in which ECs in newly formed vessels undergo selective regression to yield the mature vascular plexus (Korn and Augustin, 2015) . One indication of vascular remodeling is the emergence of empty extracellular matrix (ECM) sleeves within the capillary network, which contain ECM proteins secreted from ECs and mural cells to stabilize nascent vessels, but lack ECs. To determine whether loss of Apcdd1 causes a delay in vascular remodeling, we isolated retinas at P10 and P14 and stained for the vascular marker BSL-rhodamine and the ECM protein Collagen IV. Apcdd1 À/À and wild-type retinas were examined for empty ECM sleeves that are Collagen IV + and BSL-rhodamine À ( Figures 3I-3P , white arrows). Apcdd1 mutant mice have fewer empty ECM sleeves as compared to wild-type littermate controls at P10, but not P14 . These data suggest that loss of Apcdd1 delays vessel pruning, resulting in a hypervascularized superficial plexus.
Apcdd1 -/-Retinas Produce Neurons and Glia at Normal Levels and Have Normal Pericyte Coverage
Since Apcdd1 mRNA is expressed in both ECs and neuroglial progenitors (NBL layer) and neurons (INL layer) in the retina, we examined whether loss of Apcdd1 has any impact on differentiation of neuronal or glial cells. We performed immunofluorescence for several neuronal and glial markers in sections from P10 retinas and quantified cell numbers from both wildtype and Apcdd1 mutants. Quantification of Isl-1 (amacrine, bipolar, and ganglion cells), rhodopsin (photoreceptors), neurofilament (horizontal cells), and Sox9 (M€ uller glia) showed that Apcdd1 À/À retinas have similar numbers of neurons and M€ uller glia cells as compared to wild-type tissues ( Figures S4A-S4L ).
Norrin mRNA levels in the retina (produced primarily by M€ uller glia) were also similar between the two genotypes ( Figures  S4M and S4N ). Moreover, pericyte coverage was similar between wild-type and Apcdd1 À/À P14 retinas ( Figures S3E-S3H ). Therefore, the vascular defects observed in Apcdd1 À/À retinas are likely due to a cell-autonomous defect in the retinal endothelium rather than a secondary phenotype arising from a signaling deficit following loss of neurons, M€ uller glia, or pericytes.
The Paracellular but Not Transcellular Blood-Retina Barrier Develops Prematurely in Apcdd1 Mutants
Norrin/Fz4/Lrp5/6 signaling is necessary for BRB integrity (Wang et al., 2012; Zhou et al., 2014) , prompting us to examine whether loss of Apcdd1 affects barrier maturation of the developing retinal vasculature. To measure paracellular BRB permeability, we injected the low-molecular-weight tracer 5-(and-6)-tetramethylrhodamine biocytin (biocytin-TMR, 869 Da), which crosses the endothelial barrier when tight junctions are disrupted (Dileepan et al., 2016; Knowland et al., 2014; Lengfeld et al., 2017) , intravenously at P10, P14, and P18 and measured its distribution and levels within the retina ( Figure 4A ). At P10 and P14, wild-type retinas showed bright puncta of biocytin-TMR within the tissue parenchyma, due to tracer leakage from blood vessels and uptake into neurons (Figures 4B and 4D, white arrows). In contrast, Apcdd1 À/À retinas show less biocytin-TMR tracer within the parenchyma compared to wild-type littermate controls at both ages (P10 and P14), which is more pronounced at P14 (Figures 4C and 4E, white arrows). Biocytin-TMR levels within the retina are approximately 30% higher in wild-type compared to Apcdd1 À/À at both P10 and P14 ( Figure 4H ). However, this phenotype is transient, and by P18 both wild-type and Apcdd1 À/À retinas show comparable, negligible levels of biocytin-TMR leakage that indicate an almost mature BRB as the superficial plexus matures and ECs acquire barrier properties ( Figures 4F-4H ). Similar to the retina, the paracellular component of the blood-brain barrier (BBB) in the cerebellum forms prematurely in Apcdd1 indicating that vessel pruning and acquisition of barrier properties are distinct processes regulated in opposite directions by Apcdd1.
Because paracellular BRB permeability relies on the presence of endothelial cell junctions, we examined expression and subcellular localization of various BRB-forming TJ proteins in A second defining feature of the barrier is its low rate of transcellular trafficking. ECs within the retina have very few caveolae that express receptors for proteins delivered to the retina parenchyma, including albumin and transferrin (Chow and Gu, 2017; Daneman and Prat, 2015) . To measure transcellular permeability, we injected fluorescently labeled albumin intravenously in Apcdd1 À/À and wild-type littermates (Figure 5A) and measured the amount of albumin associated with blood vessels and retinae in various regions within the superficial vascular plexus, as previously described (Knowland et al., 2014; Lengfeld et al., 2017 
Apcdd1
À/À retinas have normal albumin uptake compared to wild-type retinas at both stages (C, E, G, and I; white arrows).
(J and K) Quantification of intra-endothelial (J) and parenchymal (K) albumin normalized to liver (n = 3-4 animals/group).
(L and M) Western blot analysis (L) and quantification (M) for Caveolin-1 and PLVAP (n = 3-4 replicates/group). Apcdd1 À/À retinal lysates have no significant differences in Caveolin-1 and PLVAP levels. Scale bars represent 50 mm in (B) and 25 mm in (C). Data in (J) and (K) are presented as mean ± SEM, and in (M) as mean ± SD; Student's unpaired t test.
stability, at least in the retina, and effectively lowering paracellular EC permeability.
Apcdd1-Deficient Brain ECs Display Altered Paracellular and Transcellular Barrier Properties
In Vitro Since Apcdd1 is expressed in non-ECs within the retina, we examined whether the changes in barrier properties seen in Apcdd1 À/À retinas are inherent to the endothelium (Paolinelli et al., 2013) . We isolated brain ECs (BECs) from P2 brains of wild-type and Apcdd1-deficient pups, using an immunopanning purification method with the endothelial marker CD31 (Daneman et al., 2010a) Figures 6E and 6F ).
However, Occludin mRNA in ECs was similar in both genotypes ( Figure S6G ). These data are consistent with our findings in vivo from Apcdd1 À/À retinas ( Figures 4Q and 4R) . Together, these results suggest that eliminating Apcdd1 in BECs increases both Occludin levels and paracellular barrier resistance, independently of other cells of the neurovascular unit.
We then performed an in vitro albumin uptake assay to measure transcellular permeability in BECs (Knowland et al., 2014; Lim et al., 2017; Tiruppathi et al., 2004 Figures 6J and 6K) ; this protein is expressed in the immature embryonic CNS endothelium and associated with fenestrated endothelium and caveolar diaphragms (Hallmann et al., 1995; Stan et al., 1999 Stan et al., , 2012 . However, addition of low levels of Wnt3a (250 ng/mL) reduced significantly the amount of albumin uptake in Apcdd1 À/À BECs ( Figure S6M ).
These results indicate that Apcdd1 À/À BECs exhibit increased transcytosis and a decreased transcellular barrier in vitro, which is restored by exposure to Wnt3a. Therefore, continuous exposure to Wnt-3a seems essential to maintain a low transcellular barrier in Apcdd1 À/À BECs.
Endothelial Apcdd1 Overexpression Promotes Vessel Pruning but Delays Paracellular Barrier Maturation in the Retina
In order to address whether Apcdd1 is sufficient to promote vessel pruning and delay barrier maturation, we generated a gain-of-function (GOF) transgenic mouse line TRE3-mApcdd1-IRES-mCherry (sTg) that overexpresses the full-length mouse Apcdd1 as well as the red fluorescent protein mCherry under the Tet-OFF binary transgenic system. We crossed Cadherin-5::tTA + transgenic mice (Sun et al., 2005) with TRE3-Apcdd1-IRES-mCherry + to generate doubly transgenic mice (dTg) ( Figure 7A ). One founder line shows no expression in sTg (TRE3-Apcdd1-IRES-mCherry + ) but strong vascular expression of mCherry in dTg (Cadherin-5::tTA + ; TRE3-Apcdd1-IRESmCherry + ) in P10 retinal blood vessels ( Figures 7B-7E ). We measured vessel densities in sTg and dTg P10 retinas and found that dTg mice have a reduced vessel density compared to sTg littermates ( Figure 7H ). We then injected biocytin-TMR intravenously at P14 in sTg and dTg mice, measured its distribution and levels within the retina, and found that dTg mice have higher biocytin-TMR levels compared to sTg mice ( Figures 7F, 7G , and 7I). Therefore, endothelial Apcdd1 overexpression produces phenotypes opposite to those of Apcdd1 À/À mice, suggesting that Apcdd1 tightly regulates vessel pruning and barrier maturation in the developing retina.
DISCUSSION
Precise control of canonical Wnt signaling is necessary for brain angiogenesis, vascular remodeling, and BBB maturation; overexpression or loss of endothelial b-catenin in the brain results in extensive CNS vascular defects and aberrant BBB formation or maintenance (Daneman et al., 2009; Liebner et al., 2008; Stenman et al., 2008; Tran et al., 2016; Zhou et al., 2014) . Similarly, loss of endothelial b-catenin signaling in the postnatal retina reduces vessel density, causing premature vessel regression with concomitant loss of BRB function (Phng et al., 2009; Wang et al., 2012; Ye et al., 2009) . How canonical Wnt signaling coordinates the timing of these two processes, as its activity progressively decreases in ECs while they transition from an angiogenic to a mature ''barrier-forming'' state, is poorly understood. Our results showing that loss of the Wnt inhibitor Apcdd1 results in increased transcriptional activity of endothelial b-catenin, leading to delayed vessel pruning but causing premature formation (legend continued on next page) of the BRB in the postnatal retina, whereas endothelial Apcdd1 overexpression produces the opposite phenotype, clarify a crucial step in this process. We discuss below how Apcdd1 sculpts Wnt activity in ECs to coordinate vascular pruning and BRB development, resulting in the mature functional vascular network of the retina. Apcdd1 is highly expressed in retinal ECs during both angiogenesis and vascular pruning, yet its role is primarily restricted to refining the exuberant immature superficial vascular network. Apcdd1-deficient mice show no defects in angiogenic sprouting or development of intra-retinal capillaries in either superficial or deep plexi, but have delayed vascular pruning. This phenotype could be a direct consequence of temporal changes in Norrin signaling within the retina. During retinal development, Norrin remains relatively constant (P1-P17), while Fz4 fluctuates with peak expression at P17. Conversely, Lrp5/6 levels are highest at P1 then steadily decrease by P7, persisting into adulthood (Chen et al., 2012) . The reduction in Lrp5/6 levels and presumably Fz4/Lrp5/6 activity at P7 corresponds to the end of angiogenic growth within the superficial plexus, EC sprouting into the outer plexiform layer and the onset of vessel pruning (Stahl et al., 2010) . We propose that during vessel pruning, ECs with intermediate levels of b-catenin activity undergo regression, while those retaining high levels of b-catenin activity fail to regress ( Figure 7J ). Apcdd1 functions at this stage to inhibit Norrin/ Fz4/Lrp5/6 signaling in the subset of retinal ECs that will undergo regression and pruning ( Figure 7J ). Consistent with this model, loss of Apcdd1 results in sustained high levels of b-catenin activity in ECs ( Figures S2G-S2O ) that block, albeit transiently, the transition from angiogenesis to vascular remodeling. The hypervascularized phenotype in Apcdd1 À/À retinas is opposite to that seen in Ndp, Fz4, and Lrp5/6 mutants or Apcdd1 GOF mice, which display reduced vessel densities in the superficial plexus (Chen et al., 2012; Luhmann et al., 2005; Xia et al., 2010; Xu et al., 2004) . Norrin overexpression upregulates several transcriptional targets including Timp3, a matrix metalloproteinase (MMP) inhibitor, pro-collagens, and pro-collagen processing enzymes that attenuate vascular remodeling by preventing vessel regression (Zhu et al., 2000) . (Chen et al., 2012; Liebner et al., 2008) , Occludin is also reduced in cerebellar ECs from Norrin-deficient mice (Wang et al., 2012) . Conversely, intra-cerebroventricular injection of recombinant Norrin following subarachnoid hemorrhage-induced BBB breakdown increases Occludin expression and reduces BBB leakage (Chen et al., 2015) . These loss-and gain-of-function studies are consistent with Occludin being a Norrin/Fz4/Lrp5 target gene. Additionally, downregulation of Occludin expression correlates with barrier breakdown during both experimentally induced diabetes (Antonetti et al., 1998) and neutrophil-induced BBB rupture (Bolton et al., 1998) , suggesting that eliminating Occludin is crucial to increase paracellular barrier permeability. Occludin belongs to the family of tight junction-associated MARVEL proteins (TAMP) that include Occludin, Tricellulin, and MarvelD3. These proteins are essential for proper regulation and positioning of tight junction proteins to cell-cell junctions.
Higher levels of Occludin could promote precocious localization of other tight junction-associated proteins to cell-cell junctions, or alter intracellular trafficking of tight junction proteins in Apcdd1 À/À as compared to wild-type ECs, as has been observed for epithelial cells (Haseloff et al., 2015) . Based on Apcdd1 loss-and gain-of-function phenotypes, we hypothesize that Apcdd1 lowers b-catenin activity to both reduce Occludin levels and delay tight junction maturation at the BRB ( Figure 7J ). While loss of Apcdd1 accelerates TJ maturation, it has no significant effect on transcellular permeability in vivo. Apcdd1 mutant mice show no differences in either albumin uptake or Caveolin-1 and PLVAP protein levels in the retina compared to wild-type littermates. However, in vitro purified Apcdd1 À/À BECs show a marked increase in albumin uptake accompanied by increased PLVAP protein. How can these findings be reconciled? In ECs, albumin is trafficked through caveolae, a subdomain of cholesterol-rich glycolipid rafts that require the GTPase activity of dynamin for membrane budding (Minshall et al., 2000) . PLVAP is an integral membrane protein that localizes to fenestrae and caveolar stomatal diaphragms (Stan et al., 2012) and is expressed transiently in immature CNS ECs until E16.5; its downregulation is necessary for a mature BBB (Hallmann et al., 1995; Zhao et al., 2015) . ECpericyte interactions are critical to downregulate PLVAP expression, because Pdgfrb À/À mice that lack pericytes show increased endothelial PLVAP expression and increased uptake of Evans blue dye in the brain (Daneman et al., 2010b) . Therefore, we hypothesize that lack of Apcdd1 in BECs promotes maintenance of PLVAP-expressing fenestrae, allowing for increased albumin uptake in vitro. This defect is likely inhibited in vivo due to pericyte-derived signals that effectively lower PLVAP expression in Apcdd1 À/À retinal ECs, because pericyte coverage is normal in BECs since addition of Wnt3a reduces the transcellular defect in isolated mutant BECs ( Figure S6M ). It was recently suggested that BRB maturation occurs primarily via a gradual suppression of transcytosis, whereas the paracellular component of the barrier forms very early (P3) in retina development (Chow and Gu, 2017) . Our findings do not support this model of BRB maturation, because we find that the paracellular component of the BRB does not mature until P18 and Apcdd1 À/À mice display premature maturation of the paracellular, but not transcellular, BRB compared to wild-type littermates.
Taken together, our loss-and gain-of-function data reveal a crucial role for Apcdd1 in regulating discrete levels of b-catenin transcriptional activity that are mediated by Norrin/Fz4/Lrp5/6 signaling in retinal ECs and are essential for vessel pruning and forming a functional barrier. On the one hand, Apcdd1 decreases endothelial b-catenin activity to induce a transcriptional program that promotes EC regression during vessel pruning, while on the other hand the presence of Apcdd1 ensures that endothelial cells with intermediate b-catenin activity, which are destined for regression, do not form a functional barrier ( Figure 7J ). By this means, Apcdd1 tightly coordinates the cessation of vascular pruning with BRB maturation to ensure that maturation does not occur prematurely in vessels that will be eliminated. Although the role of Apcdd1 as an inhibitor of Norrin/Fz4/Lrp5/6 signaling is transient, it serves to finely tune the levels of b-catenin appropriate for the various stages of angiogenesis and barrier development. Future investigations will allow us to clarify the molecular mechanisms through which these diverse effects are mediated.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines and Cell Culture Primary mouse BECs were either isolated by CD31 + immunopanning from P2 wild-type and Apcdd1 À/À pups, as described (Daneman et al., 2010a) or purchased from Cell Biologics. Both male and female wild-type or Apcdd1 À/À mice were used to isolate primary BECs from the brain. Cell were were plated on Collagen IV-coated plates and cultured in endothelial cell media supplemented with growth factors and 5% FBS (Cell Biologics) to promote formation of confluent monolayers. Cells were switched to media with low serum (1% FBS) in the absence of growth factors after reaching confluence and prior to starting experimental treatments.
Animals
All experimental procedures were approved by the IACUC regulatory bodies at Columbia University Medical Center and the University of California at Irvine.
Generation of Apcdd1 mutant mice and genotyping
We employed a previously described Apcdd1 mutant strain in which loxP sites had been engineered to flank exons 2 and 3 ( Figure S1 ) (Turakainen et al., 2009) . We crossed Apcdd1Ex2,3 flox/flox mice to a strain bearing the Cre recombinase under a heat shock promoter, which is ubiquitously expressed (Dietrich et al., 2000) , to yield Apcdd1Dex2,3 À/À mutants ( Figure S2A ). Apcdd1Dex2,3
) mutants are viable and fertile and do not exhibit any overt embryonic developmental defects. PCR primers for the Apcdd1 wild-type allele are forward (5 0 -GAGTGTCCCCGACTCCGACTCT) and reverse (5 0 -ATGTGTTGAGTTATTCCCGGAAG). PCR primers for the Apcdd1 mutant allele are forward (5 0 -GCCCATCTGGGATAGTACATGTG) and reverse (5 0 -CCTGGACT GAGGGCCATAGGTAAGAGG). Amplification was performed using Taq DNA polymerase with standard Taq buffer (New England Biolabs). PCR thermal cycler was programmed for 3 min at 94 C for initial denaturation, followed by 30 cycles of 30 s at 94 C for denaturation, 30 s at 60 C for annealing, 90 s at 72 C for extension and 10 min at 72 C for final extension. The fragment sizes for Apcdd1 wild-type and mutant alleles are 1 kb and 1.8 kb, respectively ( Figure S2B ). Both male and female wild-type or Apcdd1 À/À mice were used for experiments.
Generation of a TRE3-Apcdd1-IRES-mCherry+ transgenic strain First, a 0.7 kb SmaI/XbaI fragment containing the coding sequence for the red fluorophore mCherry was cloned into EcoRV/NheI sites within the second multiple cloning site of the pTRE3G-IRES vector (Clontech). This placed the mCherry start codon 41 nucleotides downstream of the preferential start codon after the IRES sequence, and therefore out of frame; however, translation of mCherry from this bicistronic mRNA was confirmed by tetracycline-induced transfection in HEK293 cells before constructs were injected. Next, the full-length mApcdd1 ORF (1.5 kb) was amplified using Q5 High-Fidelity DNA polymerase (New England Biolabs) with SalI (5 0 ) and ClaI (3 0 ) sites in the amplifying primers. This was cloned into the SalI/ClaI sites within the first multiple cloning site of pTRE3G-IRESmCherry to yield the complete transgene construct. The Apcdd1 sequence amplified by PCR was confirmed to be error-free by sequencing before DNA injection.
For injection into fertilized oocytes, the complete pTRE3G-Apcdd1-IRES-mCherry-SV40polyA gene ($4.3 kb) was amplified from pTRE3G using the primers TRE3Gfor (5 0 -CACGAGGCCCTTTCGTCTTCAAGAATTCCTCGAG) and SVpArev (5 0 -AAGATACATTGAT GAGTTTGGACAAACCAC) and subcloned into the pCR4-TOPO vector (Life Technologies). Clones were doubly digested with EcoRI (to release the transgene) plus SphI (to cut pCR4-TOPO into two smaller pieces) and provided to the Transgenic Mouse Facility at the University of California, Irvine. Transgenic founder animals were recovered at expected frequencies (16/103 = 16% for Apcdd1), mated individually to establish independent lines, then screened by crossing to the Cadherin-5::tTA + (Sun et al., 2005 ) driver strain to assay Tet-dependent expression of mCherry in the vascular endothelium. Both male and female sTg or dTg mice were used for experiments.
METHODS DETAILS
RNA in situ hybridization and fluorescent western blotting Both alkaline phosphatase and double fluorescent in situ hybridization were performed as described (Lengfeld et al., 2017 ) using antisense mRNA probes for full-length mouse Apcdd1, Apcdd1 (exons 2-3), Claudin-5, PDGFRb, Sox9 and Norrin. Fluorescent in situ hybridization for Apcdd1 was followed by immunostaining for Caveolin-1. Fluorescent western blot analysis and quantitation were performed as described (Knowland et al., 2014) . See Key Resources Table for specific details about the antibodies.
Tissue isolation
Retinas, cerebella and livers were harvested from wild-type and Apcdd1 À/À mice. Mice were perfused with phosphate-buffered saline (PBS) and 4% paraformaldehyde (PFA), tissue was fixed for 4 h with cold 4% PFA and washed with PBS. Whole-mount retinas were dissected to isolate the retinal cup and relieving cuts were made prior to staining. Retinas and livers collected for sectioning were cryoprotected with 30% sucrose in PBS and embedded in OCT (TissueTek, Sakura-Finetek).
Immunofluorescence Whole-mount retinas were stained with the following primary antibodies: BSL-FITC (1:500, Vector Laboratories), BSL-rhodamine (1:750, Vector Laboratories), anti-Collagen IV (1:2000, Abcam), anti-cleaved Caspase 3 (1:500, Cell Signaling) and anti-NG2 (1:500, Millipore). Imaging of whole-mount retinas was performed with a Zeiss LSM700 confocal microscope. Sectioned retinas were stained with the following primary antibodies: anti-Caveolin-1 (1:2000, Abcam), anti-Sox17 (1:50, R&D Systems), anti-Islet-1 (1:5000), anti-Sox9 (1:1000, Millipore), anti-Neurofilament (1:1000, Abcam) and anti-Rhodopsin (1:500, Abcam). Sectioned retinas were imaged with a Zeiss Axioimager.
Western blotting
Retinas, brains and livers were collected from mice after perfusion with PBS. Collected tissue was homogenized in lysis buffer containing protease and phosphatase inhibitors using a Dounce homogenizer followed by sonication. Protein levels in P10, P14 and P18 retinas were measured by fluorescent western blot analysis and quantitation was performed using the LICOR (LICOR, Lincoln, NE) system, as described (Knowland et al., 2014) . Western blot analysis used the following primary antibodies: anti-ZO-1 (1:1000, ThermoFisher Scientific), anti-Occludin (1:250, ThermoFisher), anti-Caveolin-1 (1:1000, Abcam), anti-PLVAP (1:500, ProteinTech), anti-Cadherin-5 (1:500, Abcam), anti-pLRP6 (1:500, Cell Signaling), anti-LRP6 (1:500, Cell Signaling), anti-active b-catenin (1:500, Cell Signaling), anti-b-catenin (1:500, Abcam), anti-b-actin (1:10000, Abcam) and anti-Axin2 (1:1000, Abcam). IRDyes 680 and 800 (1:10000; LI-COR) were used as secondary antibodies. Fluorescent quantification of protein levels was done using the Odyssey SA infrared imaging system. Values are displayed as protein levels corrected with b-actin and normalized to wild-type control values. Primary mouse BECs were grown on poly-D-lysine-and collagen IV-coated plates to $90% confluence in 10% FBS media, then switched to 1% FBS media for 48 hr. Cells were then harvested and lysed in RIPA buffer with protease and phosphatase inhibitors. Western blot analysis used the following primary antibodies: anti-Claudin-5 (1:2000, ThermoFisher Scientific), anti-Occludin (1:1000, ThermoFisher Scientific), anti-ZO-1 (1:1000, ThermoFisher Scientific), anti-Caveolin-1 (1:4000, Abcam), anti-Cavin 2 (1:1000, Abcam), anti-PLVAP (1:500, ProteinTech) and anti-b-actin (1:10,000, Abcam) anti-pLRP6 (1:500, Cell Signaling), anti-LRP6 (1:500, Cell Signaling), and anti-Axin2 (1:1000, Abcam). IRdyes 680 and 800 (1:20000, LI-COR) were used as secondary antibodies. Fluorescent quantification of protein levels was done using the Odyssey SA infrared imaging system. Values are displayed as protein levels corrected with b-actin and normalized to wild-type control values. Experiments were repeated five times.
Vessel density, vessel sprout number and vein diameter analysis Vessel densities for whole-mount P5-P14 retinas were measured using intersection analysis in Fiji. A 2500-5000 mm 2 grid was placed randomly over the retinal leaflet. Each intersection point of the grid served as a test point. Test points overlaying the entire leaflet vasculature from the optic nerve to the angiogenic front were counted as positive ''crossing'' points. Test points that did not overlay the vasculature were negative ''non-crossing'' points. The fractional vascular density per animal was calculated by dividing the number of crossing points by the total number of test points overlaying retina leaflets. Vessel sprout analysis was performed by counting the number of EC sprouts at the vascular front of imaged P5 whole-mount retinas in Fiji. Vein diameters of P8-P14 imaged wholemount retinas were measured in Fiji. The diameter of each vein was measured at three different locations and the values averaged.
EdU incorporation Apcdd1
À/À and wild-type littermate control animals were injected intravenously (i.v.) with 1 mL of 10 mg/mL EdU per gram body weight. After 4 hr, retinas were collected and fixed. EdU detection was performed using the Click-iT AlexaFluor 594 Imaging kit (Thermofisher Scientific). Retinas were stained with BSL-FITC (Vector Laboratories) and the superficial plexus imaged with confocal microscopy. EdU + cells that co-localize with retina vessels were counted using Fiji, and numbers of EdU + cells were normalized to the vessel area or vessel length. To calculate vessel area, the area of each analyzed leaflet was traced and measured in Fiji. The percent vessel density of each leaflet was multipled by the total area of each leaflet to generate the vessel area for each leaflet. The sum of EdU + cells for all leaflets analyzed was normalized to the sum of analyzed vessel area for each animal.
Analysis of ECM sleeves P10-P14 retinas from Apcdd1 À/À and wild-type mice were isolated and stained with BSL-rhodamine (Vector Laboratories) and Collagen IV (Abcam). ECM analysis was performed by counting empty ECM sleeves that were Collagen IV + and BSL-rhodamine À . The number of empty ECM sleeves was normalized to the vessel area as described above.
In vitro tracer leakage assay Primary mouse BECs were isolated by CD31 + immunopanning from P2 wild-type and Apcdd1 À/À pups, as described (Daneman et al., 2010a) , and were plated on Collagen IV-coated 3.0 mm pore size transwell inserts at 50,000 cells/1.1cm 2 . Cells were grown in 10% FBS media for 48 hr then switched to 1% FBS media for 24 hr. IRDye 800CW carboxylate (LICOR) tracer was added to the top chamber in a buffer containing HBSS, 4.2 mM NaHCO 3 , 10 mM HEPES and 1 mg/mL bovine serum albumin. The tracer was allowed to diffuse to the bottom chamber for 10 min. 100 mL aliquots were collected in a 96-well round-bottom plate after 5 and 10 min. Fluorescence was measured using the Odyssey SA infrared imaging system.
Transwell migration assay
Primary mouse wild-type and Apcdd1 À/À BECs were plated on fibronectin-coated 3.0 mm pore size transwell inserts at 100,000 cells/ 1.1cm 2 . Cells were grown in 10% FBS media and switched to 0.1% FBS media 4 hr prior to plating on transwell inserts. 24 hr after plating, cells were fixed with 4% PFA. Cells that had migrated to the underside of the transwell insert were stained with DAPI and counted.
QUANTIFICATION AND STATISTICAL ANALYSIS
ImageJ software was utilized for the quantitation of immunofluorescence images. Statistical analysis was performed using GraphPad Prism software version 7.0. Unpaired t test was used to compare the differences between two groups in studies. Two-way ANOVA followed by Tukey's post hoc test was performed to compare the differences among groups in the cell culture studies. Differences between groups were presented as the mean ± SEM or SD as noted in the figure legends. The sample size (n) for each experiment is indicated in the figure legends and results section. All tests were two sided and p values < 0.05 were considered to be statistically significant.
